Maureen A. Ruane and David M. Wissert

Maureen A. Ruane and David M. Wissert write: While companies may feel helpless to stem the tide of suits by whistleblowers, there are steps that companies can and should take to lessen the chances of being named as a defendant in a qui tam suit and thereby lessen the chances of being subjected to the glare of government scrutiny. Maureen A. Ruane is a partner and chair of Lowenstein Sandler's health care litigation, investigations and compliance practice; she is resident in the Roseland, N.J., office.



http://ift.tt/1Bfbwvr